Vertex Pharmaceuticals (VRTX) Financial Articles

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator... Read More

Industry: Biotechnology Sector: Healthcare

Currently in review using our new methodology check back by end of Jan 2022

Vertex Pharmaceuticals (VRTX)

Comfortable

Business Score

Financial Score

ESG Score

Report Summary

None of the business's revenue comes from Haram.
Interest is not used while running the company.
The company has a net positive impact on the environment, society and governance.

What are Halal Investors' Comfort Levels?

Our Comfort Levels are based on our analysts’ latest review of a company's business, finances, and Environmental, Social and Governance (ESG) Impact. Our reports are not meant to be understood as a religious ruling (fatwa). Rather, they represent our best efforts in trying to identify whether a company is engaged in anything forbidden in Islam (haram) and to what extent. Based on our analysis, we determine our Comfort Level with investing in the company. We encourage readers to let us know if we missed anything in the comments and to voice their agreement/disagreement by leaving a thumbs up/down. Read more about our methodology.

Loading Articles...

Vertex Pharmaceuticals (VRTX) Financial Articles

Read the full report with business, financial, & ESG analysis

Members Only

What's included

Consider these free reports

Consider these instead

Get the latest reports & insights from Halal Investors. Sign up for our newsletter.